Skip to main content

Harnessing Machine Learning for Mantle Cell Lymphoma Risk Prognostication With Adrian Mosquera Orgueira, MD, PhD

In this interview from the 2023 American Society of Hematology (ASH) Annual Meeting, Oncology Data Advisor speaks with Dr. Adrian Mosquera Orguiera, Clinical Hematologist at the University Hospital of Santiago de Compostela, about his research team's novel machine learning model that incorporates patient characteristics and histological subtype into risk prognostication for mantle cell lymphoma (MCL). In addition, Dr. Mosquera shares more of his research utilizing artificial intelligence for designing more risk-tailored therapeutic approaches and facilitate personalized medicine in hematologic malignancies.  

Continue reading

AI Beats Human Experts in Classifying Skin Lesions

A new study reports that artificial intelligence (AI) in the form of machine-learning algorithms outperforms human experts in the diagnosis of pigmented skin lesions. This web-based study, which was published in The Lancet Oncology, included 511 human readers from 63 countries. Of these, 55.4% were board-certified dermatologists, 23.1% were dermatology residents, and 16.2% were general practitioners. The human readers were asked to diagnose dermatoscopic images that had been randomly selected in...

Continue reading